PROLONG PHARMACEUTICALS INC has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in Argentina, China and Taiwan. Its main competitors in its focus markets pharmaceuticals and biotechnology are KRATZ FELIX, STEALTH PEPTIDES INTERNAT INC and QI ZHANKAI.
# | Country | Total Patents | |
---|---|---|---|
#1 | Argentina | 2 | |
#2 | China | 2 | |
#3 | Taiwan | 2 | |
#4 | Canada | 1 | |
#5 | Chile | 1 | |
#6 | Japan | 1 | |
#7 | Republic of Korea | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Abuchowski Abraham | 9 |
#2 | Lee Lihysyng Stanford | 4 |
#3 | Lee Lihsyng S | 3 |
#4 | Gitlin Gerry | 3 |
#5 | Stanford Lee Lihysyng | 1 |
#6 | O'Hare Keith | 1 |
#7 | Sloshberg Steven | 1 |
#8 | Lee Lihsyng Stanford | 1 |
#9 | Abraham Abuchowski | 1 |
Publication | Filing date | Title |
---|---|---|
TW201138831A | Modified granulocyte colony stimulating factor (G-CSF) | |
CN101534847A | Modified erythropoietin |